患有SARS-CoV-2的儿童的呼吸道联合感染
Adrianna Westbrook1, Tingyu Wang1, Kushmita Bhakta2,3
1From the Pediatric Biostatistics Core, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
The Pediatric infectious disease journal
|May 31, 2023
概括
患有SARS-CoV-2的儿童常见患有呼吸道共感染,尤其是两岁以下的儿童. 在COVID-19的儿科患者中,同时感染的可能性随着年龄的增长而降低.
科学领域:
- 儿童传染病 儿童传染病
- 呼吸系统疾病的流行病学
- 儿童的病毒共同感染
背景情况:
- 流行性呼吸道病原体的复苏需要了解小儿SARS-CoV-2病例中的共感染.
- 随着呼吸道病原体传播恢复到大流行前的水平,COVID-19儿童共感染的流行病学数据至关重要.
研究的目的:
- 确定患有SARS-CoV-2的儿科患者中经历呼吸道共感染的比例.
- 确定常见的共感染病原体,并分析共感染与患者年龄之间的关联.
主要方法:
- 使用BioFire呼吸系统面板测试呼吸系统病原体的儿科患者 (0-21岁) 的回顾性分析 2.1.
- 普森回归分析以评估共感染的可能性及其与年龄的相关性.
主要成果:
- 超过7.6%的呼吸系统面板测试为SARS-CoV-2呈阳性,其中23.7%的病例具有共感染.
- 犀牛/肠道病毒是最常见的联合感染 (15.7%),其次是腺病毒 (4.2%) 和RSV (3.5%).
- 2岁以下的儿童表现出最高的共感染率;每年增加年龄,共感染风险下降8%.
结论:
- 在小儿SARS-CoV-2患者中,呼吸道共感染很普遍.
- 共感染的可能性受病原体类型,宿主因素和时间段的影响,包括病毒变体的占主导地位和传播季节.
相关概念视频
Common Respiratory Disorders
724
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
724
Pulmonary Cycle: Exhalation
1.7K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.7K
Acute Respiratory Failure-II
291
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
291
Acute Respiratory Failure-I
256
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
256
Acute Respiratory Failure-V
171
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
171
Acute Respiratory Failure-III
237
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
237


